Macrophages in renal transplantation: Roles and therapeutic implications

Cellular Immunology

Volumn 291, Issue 1-2, 2014, Pages 58-64

  Kwan, Tony ^a   Wu, Huiling ^a   Chadban, Steven J ^a,b  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Innate immunity; Macrophages; Renal transplantation

Indexed keywords

ACUTE GRAFT REJECTION; ARTICLE; CHRONIC GRAFT REJECTION; HUMAN; KIDNEY TRANSPLANTATION; MACROPHAGE; MONOCYTE; NONHUMAN; REPERFUSION INJURY; ANIMAL; GRAFT REJECTION; IMMUNOLOGY; IMMUNOMODULATION; INFLAMMATION; KIDNEY; MOUSE; PROCEDURES;

ANIMALS; GRAFT REJECTION; HUMANS; IMMUNOMODULATION; INFLAMMATION; KIDNEY; KIDNEY TRANSPLANTATION; MICE; MONOCYTES; REPERFUSION INJURY;

EID: 84908555264     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2014.05.009     Document Type: Article

References (79)

1. Nankivell B.J., Borrows R.J., Fung C.L., O'Connell P.J., Allen R.D., Chapman J.R. The natural history of chronic allograft nephropathy. N. Eng. J. Med. 2003, 349:2326-2333.
2. Nankivell B.J., Chapman J.R. Chronic allograft nephropathy: current concepts and future directions. Transplantation 2006, 81:643-654.
3. Nankivell B.J., Alexander S.I. Rejection of the kidney allograft. N. Eng. J. Med. 2010, 363:1451-1462.
4. Lefaucheur C., Loupy A., Vernerey D., Duong-Van-Huyen J.P., Suberbielle C., Anglicheau D., Verine J., Beuscart T., Nochy D., Bruneval P., Charron D., Delahousse M., Empana J.P., Hill G.S., Glotz D., Legendre C., Jouven X. Antibody-mediated vascular rejection of kidney allografts: a population-based study. Lancet 2013, 381:313-319.
5. Auffray C., Sieweke M.H., Geissmann F. Blood monocytes: development, heterogeneity, and relationship with dendritic cells. Annu. Rev. Immunol. 2009, 27:669-692.
6. Chadban S.J., Wu H., Hughes J. Macrophages and kidney transplantation. Semin. Nephrol. 2010, 30:278-289.
7. Geissmann F., Auffray C., Palframan R., Wirrig C., Ciocca A., Campisi L., Narni-Mancinelli E., Lauvau G. Blood monocytes: distinct subsets, how they relate to dendritic cells, and their possible roles in the regulation of T-cell responses. Immunol. Cell Biol. 2008, 86:398-408.
8. Wong K.L., Yeap W.H., Tai J.J., Ong S.M., Dang T.M., Wong S.C. The three human monocyte subsets: implications for health and disease. Immunol. Res. 2012, 53:41-57.
9. Sunderkotter C., Nikolic T., Dillon M.J., Van Rooijen N., Stehling M., Drevets D.A., Leenen P.J. Subpopulations of mouse blood monocytes differ in maturation stage and inflammatory response. J. Immunol. 2004, 172:4410-4417.
10. Geissmann F., Jung S., Littman D.R. Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity 2003, 19:71-82.
11. Wong K.L., Tai J.J., Wong W.C., Han H., Sem X., Yeap W.H., Kourilsky P., Wong S.C. Gene expression profiling reveals the defining features of the classical, intermediate, and nonclassical human monocyte subsets. Blood 2011, 118:e16-31.
12. Isbel N.M., Nikolic-Paterson D.J., Hill P.A., Dowling J., Atkins R.C. Local macrophage proliferation correlates with increased renal M-CSF expression in human glomerulonephritis. Nephrol. Dial. Transplant. 2001, 16:1638-1647.
13. Matsuda M., Shikata K., Makino H., Sugimoto H., Ota Z. Glomerular expression of macrophage colony-stimulating factor and granulocyte-macrophage colony-stimulating factor in patients with various forms of glomerulonephritis. Lab. Invest. 1996, 75:403-412.
14. Mosser D.M., Edwards J.P. Exploring the full spectrum of macrophage activation. Nat. Rev. Immunol. 2008, 8:958-969.
15. Vuckovic S., Fearnley D.B., Mannering S.I., Dekker J., Whyte L.F., Hart D.N. Generation of CMRF-44+ monocyte-derived dendritic cells: insights into phenotype and function. Exp. Hematol. 1998, 26:1255-1264.
16. Zhou L.J., Tedder T.F. CD14+ blood monocytes can differentiate into functionally mature CD83+ dendritic cells. Proc. Natl. Acad. Sci. U.S.A. 1996, 93:2588-2592.
17. Banchereau J., Briere F., Caux C., Davoust J., Lebecque S., Liu Y.J., Pulendran B., Palucka K. Immunobiology of dendritic cells. Annu. Rev. Immunol. 2000, 18:767-811.
18. Wu H., Chadban S.J. Roles of Toll-like receptors in transplantation. Curr. Opin. Organ Transplant. 2014, 19:1-7.
19. Wu H., Ma J., Wang P., Corpuz T.M., Panchapakesan U., Wyburn K.R., Chadban S.J. HMGB1 contributes to kidney ischemia reperfusion injury. J. Am. Soc. Nephrol. 2010, 21:1878-1890.
20. Kielar M.L., John R., Bennett M., Richardson J.A., Shelton J.M., Chen L., Jeyarajah D.R., Zhou X.J., Zhou H., Chiquett B., Nagami G.T., Lu C.Y. Maladaptive role of IL-6 in ischemic acute renal failure. J. Am. Soc. Nephrol. 2005, 16:3315-3325.
21. Kruger B., Krick S., Dhillon N., Lerner S.M., Ames S., Bromberg J.S., Lin M., Walsh L., Vella J., Fischereder M., Kramer B.K., Colvin R.B., Heeger P.S., Murphy B.T., Schroppel B. Donor Toll-like receptor 4 contributes to ischemia and reperfusion injury following human kidney transplantation. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:3390-3395.
22. Dong X., Swaminathan S., Bachman L.A., Croatt A.J., Nath K.A., Griffin M.D. Resident dendritic cells are the predominant TNF-secreting cell in early renal ischemia-reperfusion injury. Kidney Int. 2007, 71:619-628.
23. Donnahoo K.K., Meng X., Ayala A., Cain M.P., Harken A.H., Meldrum D.R. Early kidney TNF-alpha expression mediates neutrophil infiltration and injury after renal ischemia-reperfusion. Am. J. Physiol. 1999, 277:R922-R929.
24. Wu H., Craft M.L., Wang P., Wyburn K.R., Chen G., Ma J., Hambly B., Chadban S.J. IL-18 contributes to renal damage after ischemia-reperfusion. J. Am. Soc. Nephrol. 2008, 19:2331-2341.
25. Chalasani G., Li Q., Konieczny B.T., Smith-Diggs L., Wrobel B., Dai Z., Perkins D.L., Baddoura F.K., Lakkis F.G. The allograft defines the type of rejection (acute versus chronic) in the face of an established effector immune response. J. Immunol. 2004, 172:7813-7820.
26. Hoffmann S.C., Kampen R.L., Amur S., Sharaf M.A., Kleiner D.E., Hunter K., John Swanson S., Hale D.A., Mannon R.B., Blair P.J., Kirk A.D. Molecular and immunohistochemical characterization of the onset and resolution of human renal allograft ischemia-reperfusion injury. Transplantation 2002, 74:916-923.
27. Alikhan M.A., Jones C.V., Williams T.M., Beckhouse A.G., Fletcher A.L., Kett M.M., Sakkal S., Samuel C.S., Ramsay R.G., Deane J.A., Wells C.A., Little M.H., Hume D.A., Ricardo S.D. Colony-stimulating factor-1 promotes kidney growth and repair via alteration of macrophage responses. Am. J. Pathol. 2011, 179:1243-1256.
28. Famulski K.S., Kayser D., Einecke G., Allanach K., Badr D., Venner J., Sis B., Halloran P.F. Alternative macrophage activation-associated transcripts in T-cell-mediated rejection of mouse kidney allografts. Am. J. Transplant. 2010, 10:490-497.
29. Xu H., Dhanireddy K.K., Kirk A.D. Human monocytes as intermediaries between allogeneic endothelial cells and allospecific T cells: a role for direct scavenger receptor-mediated endothelial membrane uptake in the initiation of alloimmunity. J. Immunol. 2006, 176:750-761.
30. Denton M.D., Geehan C.S., Alexander S.I., Sayegh M.H., Briscoe D.M. Endothelial cells modify the costimulatory capacity of transmigrating leukocytes and promote CD28-mediated CD4(+) T cell alloactivation. J. Exp. Med. 1999, 190:555-566.
31. Magil A.B. Infiltrating cell types in transplant glomerulitis: relationship to peritubular capillary C4d deposition. Am. J. Kidney Dis. 2005, 45:1084-1089.
32. Sund S., Reisaeter A.V., Scott H., Mollnes T.E., Hovig T. Glomerular monocyte/macrophage influx correlates strongly with complement activation in 1-week protocol kidney allograft biopsies. Clin. Nephrol. 2004, 62:121-130.
33. Alchi B., Nishi S., Kondo D., Kaneko Y., Matsuki A., Imai N., Ueno M., Iguchi S., Sakatsume M., Narita I., Yamamoto T., Gejyo F. Osteopontin expression in acute renal allograft rejection. Kidney Int. 2005, 67:886-896.
34. Grandaliano G., Gesualdo L., Ranieri E., Monno R., Stallone G., Schena F.P. Monocyte chemotactic peptide-1 expression and monocyte infiltration in acute renal transplant rejection. Transplantation 1997, 63:414-420.
35. Grau V., Gemsa D., Steiniger B., Garn H. Chemokine expression during acute rejection of rat kidneys. Scand. J. Immunol. 2000, 51:435-440.
36. Lan H.Y., Yang N., Brown F.G., Isbel N.M., Nikolic-Paterson D.J., Mu W., Metz C.N., Bacher M., Atkins R.C., Bucala R. Macrophage migration inhibitory factor expression in human renal allograft rejection. Transplantation 1998, 66:1465-1471.
37. Prodjosudjadi W., Daha M.R., Gerritsma J.S., Florijn K.W., Barendregt J.N., Bruijn J.A., van der Woude F.J., van Es L.A. Increased urinary excretion of monocyte chemoattractant protein-1 during acute renal allograft rejection. Nephrol. Dial. Transplant. 1996, 11:1096-1103.
38. Grone H.J., Weber C., Weber K.S., Grone E.F., Rabelink T., Klier C.M., Wells T.N., Proudfood A.E., Schlondorff D., Nelson P.J. Met-RANTES reduces vascular and tubular damage during acute renal transplant rejection: blocking monocyte arrest and recruitment. FASEB J. 1999, 13:1371-1383.
39. Kakuta Y., Okumi M., Miyagawa S., Tsutahara K., Abe T., Yazawa K., Matsunami K., Otsuka H., Takahara S., Nonomura N. Blocking of CCR5 and CXCR3 suppresses the infiltration of macrophages in acute renal allograft rejection. Transplantation 2012, 93:24-31.
40. Bettelli E., Carrier Y., Gao W., Korn T., Strom T.B., Oukka M., Weiner H.L., Kuchroo V.K. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 2006, 441:235-238.
41. Jose M.D., David J.R., Atkins R.C., Chadban S.J. Blockade of macrophage migration inhibitory factor does not prevent acute renal allograft rejection. Am. J. Transplant. 2003, 3:1099-1106.
42. Grau V., Herbst B., Steiniger B. Dynamics of monocytes/macrophages and T lymphocytes in acutely rejecting rat renal allografts. Cell Tissue Res. 1998, 291:117-126.
43. Hallet M.M., Praloran V., Vie H., Peyrat M.A., Wong G., Witek-Giannotti J., Soulillou J.P., Moreau J.F. Macrophage colony-stimulating factor (CSF-1) gene expression in human T-lymphocyte clones. Blood 1991, 77:780-786.
44. Le Meur Y., Jose M.D., Mu W., Atkins R.C., Chadban S.J. Macrophage colony-stimulating factor expression and macrophage accumulation in renal allograft rejection. Transplantation 2002, 73:1318-1324.
45. Jose M.D., Le Meur Y., Atkins R.C., Chadban S.J. Blockade of macrophage colony-stimulating factor reduces macrophage proliferation and accumulation in renal allograft rejection. Am. J. Transplant. 2003, 3:294-300.
46. Le Meur Y., Leprivey-Lorgeot V., Mons S., Jose M., Dantal J., Lemauff B., Aldigier J.C., Leroux-Robert C., Praloran V. Serum levels of macrophage-colony stimulating factor (M-CSF): a marker of kidney allograft rejection. Nephrol. Dial. Transplant. 2004, 19:1862-1865.
47. Teppo A.M., Honkanen E., Ahonen J., Gronhagen-Riska C. Does increased urinary interleukin-1 receptor antagonist/interleukin-1beta ratio indicate good prognosis in renal transplant recipients?. Transplantation 1998, 66:1009-1014.
48. Vamvakopoulos J., Green C., Metcalfe S. Genetic control of IL-1beta bioactivity through differential regulation of the IL-1 receptor antagonist. Eur. J. Immunol. 2002, 32:2988-2996.
49. Abdallah A.N., Billes M.A., Attia Y., Doutremepuich C., Cassaigne A., Iron A. Evaluation of plasma levels of tumour necrosis factor alpha and interleukin-6 as rejection markers in a cohort of 142 heart-grafted patients followed by endomyocardial biopsy. Eur. Heart J. 1997, 18:1024-1029.
50. Kutukculer N., Shenton B.K., Clark K., Rigg K.M., Forsythe J.L., Kirby J.A., Proud G., Taylor R.M. Renal allograft rejection: the temporal relationship and predictive value of plasma TNF (alpha and beta), IFN-gamma and soluble ICAM-1. Transplant. Int. 1995, 8:45-50.
51. Wyburn K., Wu H., Yin J., Jose M., Eris J., Chadban S. Macrophage-derived interleukin-18 in experimental renal allograft rejection. Nephrol. Dial. Transplant. 2005, 20:699-706.
52. de Oliveira J.G., Xavier P.D., Sampaio S.M., Tavares I.S., Mendes A.A. The synthesis by fine-needle aspiration biopsy cultures of IL-7, IL-16 and IL-18 is significantly associated with acute rejection in kidney transplants. Nephron 2002, 92:622-628.
53. Wyburn K., Wu H., Chen G., Yin J., Eris J., Chadban S. Interleukin-18 affects local cytokine expression but does not impact on the development of kidney allograft rejection. Am. J. Transplant. 2006, 6:2612-2621.
54. Magil A.B. Monocytes/macrophages in renal allograft rejection. Transplant. Rev. (Orlando) 2009, 23:199-208.
55. McLean A.G., Hughes D., Welsh K.I., Gray D.W., Roake J., Fuggle S.V., Morris P.J., Dallman M.J. Patterns of graft infiltration and cytokine gene expression during the first 10 days of kidney transplantation. Transplantation 1997, 63:374-380.
56. grauBurkhard K., Hofmann G.O., Bosnecker A., Hillebrand G., Illner W.D., Petersen P., Land W. Early infiltration of renal allografts with 27E10-positive macrophages and graft outcome. Transplant. Int. 1994, 7(Suppl 1):S577-S579.
57. Girlanda R., Kleiner D.E., Duan Z., Ford E.A., Wright E.C., Mannon R.B., Kirk A.D. Monocyte infiltration and kidney allograft dysfunction during acute rejection. Am. J. Transplant. 2008, 8:600-607.
58. Grimm P.C., McKenna R., Nickerson P., Russell M.E., Gough J., Gospodarek E., Liu B., Jeffery J., Rush D.N. Clinical rejection is distinguished from subclinical rejection by increased infiltration by a population of activated macrophages. J. Am. Soc. Nephrol. 1999, 10:1582-1589.
59. Worrall N.K., Lazenby W.D., Misko T.P., Lin T.S., Rodi C.P., Manning P.T., Tilton R.G., Williamson J.R., Ferguson T.B. Modulation of in vivo alloreactivity by inhibition of inducible nitric oxide synthase. J. Exp. Med. 1995, 181:63-70.
60. Jose M.D., Ikezumi Y., van Rooijen N., Atkins R.C., Chadban S.J. Macrophages act as effectors of tissue damage in acute renal allograft rejection. Transplantation 2003, 76:1015-1022.
61. Dehmel S., Wang S., Schmidt C., Kiss E., Loewe R.P., Chilla S., Schlondorff D., Grone H.-J., Luckow B. Chemokine receptor Ccr5 deficiency induces alternative macrophage activation and improves long-term renal allograft outcome. Eur. J. Immunol. 2010, 40:267-278.
62. Diao J., Mikhailova A., Tang M., Gu H., Zhao J., Cattral M.S. Immunostimulatory conventional dendritic cells evolve into regulatory macrophage-like cells. Blood 2012, 119:4919-4927.
63. Briganti E.M., Russ G.R., McNeil J.J., Atkins R.C., Chadban S.J. Risk of renal allograft loss from recurrent glomerulonephritis. N. Eng. J. Med. 2002, 347:103-109.
64. Wang Y., Harris D.C. Macrophages in renal disease. J. Am. Soc. Nephrol. 2011, 22:21-27.
65. Azuma H., Heemann U., Tullius S.G., Tilney N.L. Host leukocytes and their products in chronic kidney allograft rejection in rats. Transplant. Int. 1994, 7(Suppl. 1):S325-S327.
66. Diamond J.R., Tilney N.L., Frye J., Ding G., McElroy J., Pesek-Diamond I., Yang H. Progressive albuminuria and glomerulosclerosis in a rat model of chronic renal allograft rejection. Transplantation 1992, 54:710-716.
67. Fahim T., Bohmig G.A., Exner M., Huttary N., Kerschner H., Kandutsch S., Kerjaschki D., Brambock A., Nagy-Bojarszky K., Regele H. The cellular lesion of humoral rejection: predominant recruitment of monocytes to peritubular and glomerular capillaries. Am. J. Transplant. 2007, 7:385-393.
68. Wang Y., Wang Y.P., Zheng G., Lee V.W.S., Ouyang L., Chang D.H.H., Mahajan D., Coombs J., Wang Y.M., Alexander S.I., Harris D.C.H. Ex vivo programmed macrophages ameliorate experimental chronic inflammatory renal disease. Kidney Int. 2007, 72:290-299.
69. Pilmore H.L., Painter D.M., Bishop G.A., McCaughan G.W., Eris J.M. Early up-regulation of macrophages and myofibroblasts: a new marker for development of chronic renal allograft rejection. Transplantation 2000, 69:2658-2662.
70. Croker B.P., Clapp W.L., Abu Shamat A.R., Kone B.C., Peterson J.C. Macrophages and chronic renal allograft nephropathy. Kidney Int. Suppl. 1996, 57:S42-S49.
71. Getts D.R., Terry R.L., Getts M.T., Deffrasnes C., Muller M., van Vreden C., Ashhurst T.M., Chami B., McCarthy D., Wu H., Ma J., Martin A., Shae L.D., Witting P., Kansas G.S., Kuhn J., Hafezi W., Campbell I.L., Reilly D., Say J., Brown L., White M.Y., Cordwell S.J., Chadban S.J., Thorp E.B., Bao S., Miller S.D., King N.J. Therapeutic inflammatory monocyte modulation using immune-modifying microparticles. Sci. Transl. Med. 2014, 6. 219ra217.
72. Venugopal V., Laing C.M., Ludman A., Yellon D.M., Hausenloy D. Effect of remote ischemic preconditioning on acute kidney injury in nondiabetic patients undergoing coronary artery bypass graft surgery: a secondary analysis of 2 small randomized trials. Am. J. Kidney Dis. 2010, 56:1043-1049.
73. Zimmerman R.F., Ezeanuna P.U., Kane J.C., Cleland C.D., Kempananjappa T.J., Lucas F.L., Kramer R.S. Ischemic preconditioning at a remote site prevents acute kidney injury in patients following cardiac surgery. Kidney Int. 2011, 80:861-867.
74. Cho W.Y., Choi H.M., Lee S.Y., Kim M.G., Kim H.-K., Jo S.-K. The role of Tregs and CD11c(+) macrophages/dendritic cells in ischemic preconditioning of the kidney. Kidney Int. 2010, 78:981-992.
75. Wu H., Steenstra R., de Boer E.C., Zhao C.Y., Ma J., van der Stelt J.M., Chadban S.J. Preconditioning with recombinant high-mobility group box 1 protein protects the kidney against ischemia-reperfusion injury in mice. Kidney Int. 2013.
76. Schroder C., Pierson R.N., Nguyen B.-N.H., Kawka D.W., Peterson L.B., Wu G., Zhang T., Springer M.S., Siciliano S.J., Iliff S., Ayala J.M., Lu M., Mudgett J.S., Lyons K., Mills S.G., Miller G.G., Singer I.I., Azimzadeh A.M., DeMartino J.A. CCR5 blockade modulates inflammation and alloimmunity in primates. J. Immunol. 2007, 179:2289-2299.
77. Leuschner F., Dutta P., Gorbatov R., Novobrantseva T.I., Donahoe J.S., Courties G., Lee K.M., Kim J.I., Markmann J.F., Marinelli B., Panizzi P., Lee W.W., Iwamoto Y., Milstein S., Epstein-Barash H., Cantley W., Wong J., Cortez-Retamozo V., Newton A., Love K., Libby P., Pittet M.J., Swirski F.K., Koteliansky V., Langer R., Weissleder R., Anderson D.G., Nahrendorf M. Therapeutic siRNA silencing in inflammatory monocytes in mice. Nat. Biotechnol. 2011, 29:1005-1010.
78. Vos A.C.W., Wildenberg M.E., Duijvestein M., Verhaar A.P., van den Brink G.R., Hommes D.W. Anti-tumor necrosis factor- antibodies induce regulatory macrophages in an Fc region-dependent manner. Gastroenterology 2011, 140:221-230.
79. Hutchinson J.A., Riquelme P., Sawitzki B., Tomiuk S., Miqueu P., Zuhayra M., Oberg H.H., Pascher A., Lutzen U., Janssen U., Broichhausen C., Renders L., Thaiss F., Scheuermann E., Henze E., Volk H.-D., Chatenoud L., Lechler R.I., Wood K.J., Kabelitz D., Schlitt H.J., Geissler E.K., Fandrich F. Cutting edge: immunological consequences and trafficking of human regulatory macrophages administered to renal transplant recipients. J. Immunol. 2011, 187:2072-2078.